9 Facts About Saffron and Why It Is Getting Serious Research Attention for Menopause Mood and Libido
When the mood dips and the desire disappears, it is easy to feel like something has just switched off permanently. Discovering that a spice with real clinical trials behind it might help — not cure, but genuinely help — felt like finding a small, unexpected door. That is exactly what saffron represents right now: not a miracle, but a legitimate option worth knowing about.
Learn more about Rose →Saffron's Active Compounds Work Directly on Serotonin Pathways
The main bioactive compounds in saffron — crocin, crocetin, and safranal — have been shown in laboratory and human studies to inhibit the reuptake of serotonin, the same basic mechanism used by SSRI antidepressants. This means saffron is not simply a 'mood-boosting herb' in a vague sense; it has a plausible and specific neurochemical action. For perimenopausal women whose serotonin signalling is already disrupted by falling oestrogen, this pathway matters.
The Clinically Studied Dose Is Surprisingly Small — 30mg Per Day
Across the majority of published trials, the effective dose of saffron extract is 30mg per day, typically split into two 15mg doses, which is a tiny fraction of what is used in cooking. This dose is important to note because it means women cannot simply add more saffron to their food and expect the same effect — the studies use standardised extracts with consistent concentrations of active compounds. Anything labelled just 'saffron powder' without a stated extract ratio is unlikely to deliver a reliable dose.
Multiple Randomised Trials Have Compared Saffron Directly to Antidepressants
Several small but properly controlled RCTs have compared 30mg of saffron extract to fluoxetine (Prozac) or imipramine for mild to moderate depression and found comparable outcomes over 6–8 weeks. These are not large trials — most have fewer than 100 participants — but they are randomised, double-blind, and placebo-controlled, which places them a meaningful step above anecdote. The fact that pharmaceutical companies have little financial incentive to fund saffron research makes the existence of these independent trials notable.
There Is Specific Trial Data on Saffron for Perimenopausal Women
A 2021 randomised controlled trial published in the journal Nutrients followed women aged 35–60 with self-reported low mood and perimenopausal symptoms, finding that 30mg of saffron extract daily produced significant improvements in depression scores and total menopause symptom burden compared to placebo after 12 weeks. This is not extrapolated data from general population depression studies — it was run specifically in this age group. The sample size was modest (about 56 women), but the study design was solid.
Saffron Has Been Studied for Sexual Dysfunction in Women — and the Results Are Meaningful
A placebo-controlled trial published in Human Psychopharmacology found that women taking saffron extract reported significantly improved arousal, lubrication, and pain scores on the Female Sexual Function Index compared to the placebo group. The researchers hypothesised that saffron's dopaminergic activity — its ability to influence dopamine signalling as well as serotonin — may be part of the mechanism behind improved desire and arousal. For perimenopausal women dealing with low libido that is not explained by relationship factors alone, this is a credible avenue to explore.
It May Also Counter the Sexual Side Effects of Antidepressants
One of the more unexpected findings in the saffron literature is its potential to reduce antidepressant-induced sexual dysfunction — a side effect that affects a significant proportion of people taking SSRIs and is a common reason women quietly stop their medication. A small RCT in women taking fluoxetine found that adding saffron extract improved sexual function scores over four weeks compared to placebo. This is early data, but it points to saffron working through a complementary rather than competing mechanism.
Saffron Shows Anti-Inflammatory and Antioxidant Properties That May Support Brain Health
Beyond serotonin, crocin and crocetin have demonstrated antioxidant and anti-neuroinflammatory effects in cell and animal studies, with some early human data suggesting protective effects on memory and cognition. Neuroinflammation is increasingly being studied as a factor in perimenopausal brain fog and mood dysregulation, which gives saffron's effects a potentially broader relevance than pure antidepressant action. This area is still emerging and should not be overstated, but it is a legitimate reason researchers are paying closer attention.
The Safety Profile in Short-Term Studies Is Reassuring — With a Few Caveats
At the 30mg therapeutic dose, saffron has shown a good tolerability profile in trials up to 12 weeks, with side effects rarely exceeding those of placebo — typically mild nausea or headache in a small number of participants. However, very high doses (above 5 grams) are toxic and have been historically associated with miscarriage, which means saffron supplementation is firmly contraindicated during pregnancy. Long-term safety data beyond 12 weeks is limited, and women on anticoagulants or mood medications should discuss it with a clinician before starting.
Saffron Is a Complement to Evidence-Based Treatment — Not a Replacement for It
It is important to be honest about what saffron cannot do: the existing trials cover mild to moderate depression and general sexual function scores, not severe mood disorders, genitourinary syndrome of menopause, or the vasomotor symptoms like hot flushes and night sweats that significantly disrupt sleep and quality of life. Hormone therapy remains the most effective and best-evidenced intervention for the full symptom picture of perimenopause and menopause, and saffron does not address the underlying hormonal shift. For women who cannot or choose not to use hormones, saffron is one of the more evidence-supported additions to a broader strategy — but it works best alongside, not instead of, appropriate medical care.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.